eNauka - pregled

Pregled prema Projekat Daiichi-Sankyo Pharma Inc

Prikaz rezultata 1 do 1 od 1
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2017Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)Link, Mark S; ...; Mitrovic, Veselin; ...; Apostolovic, Svetlana R  ; Djordjevic-Radojkovic, Danijela  ; Celic, Vera P  ; Majstorovic, Anka R; Cemerlic-Adjic, Nada B  ; Bjelobrk, Marija  ;
Despotovic, Nebojsa  ; Erceg, Predrag  ; Ilic, Stevan N; Ilic, Bojan I; Krotin, Mirjana K ; Djokovic, Aleksandra  ; Miloradovic, Vladimir M  ; Djokic, I; Otasevic, Petar M  ; Tasic, Nebojsa M; Potpara, Tatjana S  ; Polovina, Marija M  ; Putnikovic, Biljana ; Kalezic, T; Seferovic, Petar M ; Milinkovic, Ivan M; Tavciovski, Dragan; Davicevic, Zaklina S; Vasiljevic-Pokrajcic, Zorana M ; Mitrovic, Predrag M; Vujisic-Tesic, Bosiljka D ; Ostojic, Miodrag C; ...; Tesic, Milorad B  ; ...; (broj, koautora 2696);
Article
21aM21a